Dissolution and supersaturation episodes of nimodipine in the aqueous solutions of the cyclodextrins α-CD, HP-α-CD, M-β-CD, and HP-γ-CD;Rozpustanie a javy presytenia nimodipinu vo vodnynch roztokoch cyklodextrinov α-CD, HP-α-CD, M-β-CD a HP-γ-CD

Ceska a Slovenska Farmacie

Volumn 48, Issue 6, 1999, Pages 287-290

  Kopecky F ^a   Kopecka B ^a   Kaclik P ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Calcium antagonist; Cyclodextrins; Nimodipine; Solubilisation; Supersaturated solutions

Indexed keywords

ALPHA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; DRUG SOLVENT; HYDROXYPROPYL ALPHA CYCLODEXTRIN; HYDROXYPROPYL GAMMA CYCLODEXTRIN; METHYL BETA CYCLODEXTRIN; NIMODIPINE; UNCLASSIFIED DRUG; CALCIUM CHANNEL BLOCKING AGENT; CYCLODEXTRIN;

AQUEOUS SOLUTION; ARTICLE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG SOLUTION; ORAL DRUG ADMINISTRATION; CHEMISTRY; SOLUBILITY; SOLUTION AND SOLUBILITY;

CALCIUM CHANNEL BLOCKERS; CYCLODEXTRINS; NIMODIPINE; SOLUBILITY; SOLUTIONS;

EID: 0033223081     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Langley, M., Sorkin, E. M.: Drugs 37, 669 (1989).
2. Mück, W., Bode, H.: Pharmazie 49, 130 (1994).
3. Hároníková, K., Kopecká, B., Benedikovič, I.: Farm. Obzor 63, 13 (1994).
4. MacKenzie, C. R., Fawcet, J. P., Boulton, D. W., Tucker, I. G.: Int. J. Pharm. 159, 191 (1997).
5. Thompson, D. O.: Crit. Rev. Ther. Drug. Carr. Syst. 14, 1 (1997).
6. Kopecký, F., Vojteková, M., Výbohová, J.: Pharma Journal 8 (6), 159 (1998).
7. Kopecký, F., Kopecká, B., Kaclík, P., Struhárová, D.: Čes. a Slov. Farm. 47, 233 (1998).
8. Torres-Labandeira, J. J., Pitha, J.: In: Minutes of the Fifth International Symposium on Cyclodextrins (Duchene, D., ed.), Editions de Santé, Paris 1990, p. 495.
9. Pedersen, M.: Drug. Develop. Ind. Pharm. 23, 331 (1997).
10. Pedersen, M., Bjerregaard, S., Jacobsen, J. et al.: Int. J. Pharm. 165, 57 (1998).